Dr Naughton is based at UEA and also holds honorary positions as Associate Professor at the University of Nottingham and Senior Visiting Researcher at the University of Cambridge. He leads a programme of research developing and evaluating tailored digital smoking cessation interventions. He also undertakes research in the areas of smoking in pregnancy, smoking cessation medication adherence and e-cigarettes. He has authored over 70 scientific papers and has served on several funding boards and advisory committees. He is an Associate Editor for Addiction.

Carole Clair is a general internist and a researcher, and is the co-head of the Department of Education, Research and Innovation at the Center for Primary Care and Public Health at the University of Lausanne, Switzerland. She works as a lecturer and shares her time between teaching, clinical activities in general internal medicine and smoking cessation clinic and research. Her main research interest is the interaction between smoking and metabolism. Dr. Clair is the principal investigator of randomized controlled trial assessing the efficacy and metabolic impact of a smoking cessation intervention in people with type 2 diabetes. Since 2013, she is an Associate Editor for SRNT’s journal Nicotine and Tobacco Research. She is the chair of the local organising committee for the 2021 SRNT-E conference, which will be held in Lausanne, Switzerland.

Ute Mons is a University Professor of Cardiovascular Epidemiology of Aging at the University of Cologne, Germany. She holds an M.A. in Sociology and Economics, and a PhD in Epidemiology and Public Health from the University of Heidelberg. She has co-authored more than 100 research publications, mostly in her main research areas tobacco control, cancer prevention, and chronic disease epidemiology. In these areas, Ute Mons is involved in several national and international research projects, including being PI of the International Tobacco Control Policy Evaluation Project (ITC) Germany project. Ute Mons also participates in several national committees to promote public health and tobacco control. In 2017, she was awarded one of the ECL ECTOH Young Professional Awards recognizing her contribution to tobacco control.

Lynne Dawkins is an Associate Professor of Psychology at the School of Applied Science of London South Bank University. She has worked in the field of nicotine and tobacco research for 20 years and was among the first to demonstrate specific abstinence-related cognitive and motivational impairments in smokers, to map trajectories of recovery, and predictive utility for cessation. In part of her research she pioneered in the field of e-cigarettes describing user profiles and patterns of use; effects on cigarette craving/withdrawal symptoms; device characteristics and comparisons; puffing topographies, and pharmacokinetic profiles. This work has fed into UK Tobacco Control Policy. Dr Dawkins is currently in receipt of CRUK funding to explore effects of nicotine e-liquid concentrations on puffing patterns and carbonyl exposure and effects of the TPD E-cigarette warning labels on risk perceptions/intentions to use.

Dr Gemma Taylor is the Research Director for The Addiction and Mental Health Group (AIM). Dr Taylor is an epidemiologist and behavioural scientist, and currently holds a prestigious post-doctoral fellowship award from Cancer Research UK. Dr Taylor has pinoeered research on smoking cessation and mental health, and currently leads a programme of work developing integrated smoking cessation interventions for people with mental illness designed for use in NHS psychology settings. Dr Taylor is an associate editor for Addiction.

Professor Munafò’s research focuses on understanding pathways into, and the consequences of, health behaviours and mental health, with a particular focus on tobacco and alcohol use. This work incudes: 1) observational and genetic epidemiology, and the use of a range of methods that enable stronger causal inference from observational data, such as negative control and Mendelian randomization methods; 2) the laboratory study of cognitive and neurobiological mechanistic pathways that underpin exposure-outcome relationships; and 3) the development of novel individual- and population-level interventions that target these mechanisms, including choice architecture interventions. This work has informed ongoing policy debates, such as the introduction of standardised (“plain”) packaging for tobacco products. He also has interests in the role of incentive structures in science, and the extent to which these shape the robustness and reproducibility of scientific research.

Olivia Maynard is a Co-Director of the Tobacco and Alcohol Research Group (TARG) at the University of Bristol. She leads a programme of research examining how best to design nicotine and tobacco messaging and warning labels. She is also interested in harm reduction, perceptions of risk and misperceptions surrounding these products. Her research on standardised packaging of tobacco products has been used to inform policy debates worldwide. She is an Associate Editor for Nicotine and Tobacco Research and Addiction.